These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex. Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423 [TBL] [Abstract][Full Text] [Related]
12. Exploring the interaction mechanism between potential inhibitor and multi-target Mur enzymes of mycobacterium tuberculosis using molecular docking, molecular dynamics simulation, principal component analysis, free energy landscape, dynamic cross-correlation matrices, vector movements, and binding free energy calculation. Kumari M; Singh R; Subbarao N J Biomol Struct Dyn; 2022; 40(24):13497-13526. PubMed ID: 34662260 [TBL] [Abstract][Full Text] [Related]
13. Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of Mahfuz AMUB; Stambuk Opazo F; Aguilar LF; Iqbal MN J Biomol Struct Dyn; 2022 Jun; 40(9):4021-4037. PubMed ID: 33251968 [TBL] [Abstract][Full Text] [Related]
14. Solution structures of Mycobacterium tuberculosis thioredoxin C and models of intact thioredoxin system suggest new approaches to inhibitor and drug design. Olson AL; Neumann TS; Cai S; Sem DS Proteins; 2013 Apr; 81(4):675-89. PubMed ID: 23229911 [TBL] [Abstract][Full Text] [Related]
15. Refined homology model of cytochrome bcc complex B subunit for virtual screening of potential anti-tuberculosis agents. Pan Z; Wang Y; Gu X; Wang J; Cheng M J Biomol Struct Dyn; 2020 Oct; 38(16):4733-4745. PubMed ID: 31674290 [TBL] [Abstract][Full Text] [Related]
16. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity. Ng HL; Chen S; Chew EH; Chui WK Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844 [TBL] [Abstract][Full Text] [Related]
17. Reduction of peroxides and dinitrobenzenes by Mycobacterium tuberculosis thioredoxin and thioredoxin reductase. Zhang Z; Hillas PJ; Ortiz de Montellano PR Arch Biochem Biophys; 1999 Mar; 363(1):19-26. PubMed ID: 10049495 [TBL] [Abstract][Full Text] [Related]
18. Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations. Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN Tuberculosis (Edinb); 2020 Mar; 121():101920. PubMed ID: 32279872 [TBL] [Abstract][Full Text] [Related]
19. Protein-protein interactions at an enzyme-substrate interface: characterization of transient reaction intermediates throughout a full catalytic cycle of Escherichia coli thioredoxin reductase. Negri A; Rodríguez-Larrea D; Marco E; Jiménez-Ruiz A; Sánchez-Ruiz JM; Gago F Proteins; 2010 Jan; 78(1):36-51. PubMed ID: 19585660 [TBL] [Abstract][Full Text] [Related]
20. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol. Huang J; Xu J; Tian L; Zhong L Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]